Related Experiment Video
Updated: May 9, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Autophagy in Obesity and Type 2 Diabetes: Beyond the Protective Paradigm
M Elena Angarita-Plánchez1,2, Paula Sánchez-Rodríguez1, Ana M Múnera-Rodríguez1
1Department of Medical Biochemistry, Molecular Biology and Immunology, Faculty of Medicine, University of Seville. Av. Sánchez Pizjuan S/N, 41009, Seville, Spain.
Autophagy dysregulation in obesity and type 2 diabetes mellitus (T2DM) is tissue-specific, not uniformly suppressed. Understanding this context-dependent maladaptation is key for developing precision therapies.
Area of Science:
- Cellular Biology
- Metabolic Disease Research
Background:
- Autophagy plays a crucial role in cellular homeostasis.
- Dysregulation of autophagy is implicated in various metabolic disorders, including obesity and type 2 diabetes mellitus (T2DM).
Purpose of the Study:
- To review current evidence on autophagy dysregulation in obesity and T2DM.
- To emphasize the tissue-specific nature of these autophagic alterations.
- To explore the implications for clinical translation and therapeutic strategies.
Main Methods:
- Review of preclinical and human studies on autophagy markers (LC3, p62, Beclin-1) in metabolic diseases.
- Analysis of signaling pathways involved (mTORC1-AMPK).
- Examination of recent advances in assessing autophagic flux and biomarkers.
Main Results:
- Autophagic alterations in metabolic disease are tissue- and stage-dependent, not uniformly suppressed.
- Dysregulated signaling, mitophagy, and lysosomal function contribute to insulin resistance and metaflammation in key tissues.
- Current human studies often rely on static markers, limiting reliable assessment of autophagic flux.
Conclusions:
- Autophagy in metabolic disease is a context-dependent maladaptation.
- New biomarkers and functional assays are needed for accurate assessment of autophagic flux in humans.
- Integrating these with metabolic phenotyping is crucial for precision therapeutic strategies.
More Related Videos
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type I Diabetes II: Pathophysiology

